Laryngoscope:前庭神经鞘瘤患者中听力重建使用趋势分析

2019-10-12 AlexYang MedSci原创

大多数患有前庭神经鞘瘤(VS)的患者在受影响的耳朵中具有明显的听力损失,并且是肿瘤或者治疗引起。而在听力重建的选择中却缺乏相关数据。最近,有研究人员分析了VS患者中听力重建设备的使用情况。研究包括了单边VS治疗的患者,时间为2008年1月到2018年8月,并排除了那些双边VS、对侧耳永久性听力损失、2型神经纤维瘤或者没有充分跟踪调查的患者。研究共包括了21名符合标准的患者,61名患者完成了所有调查

大多数患有前庭神经鞘瘤(VS)的患者在受影响的耳朵中具有明显的听力损失,并且是肿瘤或者治疗引起。而在听力重建的选择中却缺乏相关数据。最近,有研究人员分析了VS患者中听力重建设备的使用情况。

研究包括了单边VS治疗的患者,时间为2008年1月到2018年8月,并排除了那些双边VS、对侧耳永久性听力损失、2型神经纤维瘤或者没有充分跟踪调查的患者。研究共包括了21名符合标准的患者,61名患者完成了所有调查。研究发现,大多数(88%)患者在受影响的耳朵中听力很差或者丧失听力,但是使用听力重加设备的患者却少于三分之一。大多数患者使用过传统的助听器(30%)或者信号对传线路/双侧信号对传线路(30%),然而只有一小部分患者使用过骨锚定的听力设备或者耳蜗移植。那些没有进行听力重建的患者要么没有被他们的缺陷所困扰,要么没有意识到他们的选择。尽管有缺陷,但大多数功能良好。

最后,研究人员指出,尽管88%的患者在VS治疗后具有明显的听力损失,大多数并没有寻求听力重建且功能表现良好,并且大多数患者并不记得听力重建的选择,因此常规和重复的咨询是需要的,从而增加患者VS治疗后对听力重建的使用。

原始出处:

Drusin MA, Lubor B, Losenegger T et al. Trends in hearing rehabilitation use among vestibular schwannoma patients. Laryngoscope. 11 Oct 2019

本文系梅斯医学(MedSci)原创编译整理,转载需授权!

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1728162, encodeId=085f1e2816211, content=<a href='/topic/show?id=986913980dd' target=_blank style='color:#2F92EE;'>#PE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13980, encryptionId=986913980dd, topicName=PE)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f06c33759375, createdName=feather89, createdTime=Wed Nov 20 17:09:00 CST 2019, time=2019-11-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2076453, encodeId=712b20e645362, content=<a href='/topic/show?id=d7453259e86' target=_blank style='color:#2F92EE;'>#前庭神经#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=32597, encryptionId=d7453259e86, topicName=前庭神经)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ec37461, createdName=szhvet, createdTime=Wed Feb 12 14:09:00 CST 2020, time=2020-02-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1667571, encodeId=2bd2166e57146, content=<a href='/topic/show?id=b9559296103' target=_blank style='color:#2F92EE;'>#趋势分析#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=92961, encryptionId=b9559296103, topicName=趋势分析)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=20bf26147921, createdName=bugit, createdTime=Fri Apr 17 14:09:00 CST 2020, time=2020-04-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1306434, encodeId=233b130643437, content=<a href='/topic/show?id=aeb639230b7' target=_blank style='color:#2F92EE;'>#听力#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=39230, encryptionId=aeb639230b7, topicName=听力)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=96d4340, createdName=ysjykql, createdTime=Mon Oct 14 09:09:00 CST 2019, time=2019-10-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1340189, encodeId=15c4134018977, content=<a href='/topic/show?id=d0c3e4615f2' target=_blank style='color:#2F92EE;'>#神经鞘瘤#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=74615, encryptionId=d0c3e4615f2, topicName=神经鞘瘤)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=48732500158, createdName=12498c32m68暂无昵称, createdTime=Mon Oct 14 09:09:00 CST 2019, time=2019-10-14, status=1, ipAttribution=)]
    2019-11-20 feather89
  2. [GetPortalCommentsPageByObjectIdResponse(id=1728162, encodeId=085f1e2816211, content=<a href='/topic/show?id=986913980dd' target=_blank style='color:#2F92EE;'>#PE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13980, encryptionId=986913980dd, topicName=PE)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f06c33759375, createdName=feather89, createdTime=Wed Nov 20 17:09:00 CST 2019, time=2019-11-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2076453, encodeId=712b20e645362, content=<a href='/topic/show?id=d7453259e86' target=_blank style='color:#2F92EE;'>#前庭神经#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=32597, encryptionId=d7453259e86, topicName=前庭神经)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ec37461, createdName=szhvet, createdTime=Wed Feb 12 14:09:00 CST 2020, time=2020-02-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1667571, encodeId=2bd2166e57146, content=<a href='/topic/show?id=b9559296103' target=_blank style='color:#2F92EE;'>#趋势分析#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=92961, encryptionId=b9559296103, topicName=趋势分析)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=20bf26147921, createdName=bugit, createdTime=Fri Apr 17 14:09:00 CST 2020, time=2020-04-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1306434, encodeId=233b130643437, content=<a href='/topic/show?id=aeb639230b7' target=_blank style='color:#2F92EE;'>#听力#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=39230, encryptionId=aeb639230b7, topicName=听力)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=96d4340, createdName=ysjykql, createdTime=Mon Oct 14 09:09:00 CST 2019, time=2019-10-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1340189, encodeId=15c4134018977, content=<a href='/topic/show?id=d0c3e4615f2' target=_blank style='color:#2F92EE;'>#神经鞘瘤#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=74615, encryptionId=d0c3e4615f2, topicName=神经鞘瘤)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=48732500158, createdName=12498c32m68暂无昵称, createdTime=Mon Oct 14 09:09:00 CST 2019, time=2019-10-14, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1728162, encodeId=085f1e2816211, content=<a href='/topic/show?id=986913980dd' target=_blank style='color:#2F92EE;'>#PE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13980, encryptionId=986913980dd, topicName=PE)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f06c33759375, createdName=feather89, createdTime=Wed Nov 20 17:09:00 CST 2019, time=2019-11-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2076453, encodeId=712b20e645362, content=<a href='/topic/show?id=d7453259e86' target=_blank style='color:#2F92EE;'>#前庭神经#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=32597, encryptionId=d7453259e86, topicName=前庭神经)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ec37461, createdName=szhvet, createdTime=Wed Feb 12 14:09:00 CST 2020, time=2020-02-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1667571, encodeId=2bd2166e57146, content=<a href='/topic/show?id=b9559296103' target=_blank style='color:#2F92EE;'>#趋势分析#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=92961, encryptionId=b9559296103, topicName=趋势分析)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=20bf26147921, createdName=bugit, createdTime=Fri Apr 17 14:09:00 CST 2020, time=2020-04-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1306434, encodeId=233b130643437, content=<a href='/topic/show?id=aeb639230b7' target=_blank style='color:#2F92EE;'>#听力#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=39230, encryptionId=aeb639230b7, topicName=听力)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=96d4340, createdName=ysjykql, createdTime=Mon Oct 14 09:09:00 CST 2019, time=2019-10-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1340189, encodeId=15c4134018977, content=<a href='/topic/show?id=d0c3e4615f2' target=_blank style='color:#2F92EE;'>#神经鞘瘤#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=74615, encryptionId=d0c3e4615f2, topicName=神经鞘瘤)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=48732500158, createdName=12498c32m68暂无昵称, createdTime=Mon Oct 14 09:09:00 CST 2019, time=2019-10-14, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1728162, encodeId=085f1e2816211, content=<a href='/topic/show?id=986913980dd' target=_blank style='color:#2F92EE;'>#PE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13980, encryptionId=986913980dd, topicName=PE)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f06c33759375, createdName=feather89, createdTime=Wed Nov 20 17:09:00 CST 2019, time=2019-11-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2076453, encodeId=712b20e645362, content=<a href='/topic/show?id=d7453259e86' target=_blank style='color:#2F92EE;'>#前庭神经#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=32597, encryptionId=d7453259e86, topicName=前庭神经)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ec37461, createdName=szhvet, createdTime=Wed Feb 12 14:09:00 CST 2020, time=2020-02-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1667571, encodeId=2bd2166e57146, content=<a href='/topic/show?id=b9559296103' target=_blank style='color:#2F92EE;'>#趋势分析#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=92961, encryptionId=b9559296103, topicName=趋势分析)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=20bf26147921, createdName=bugit, createdTime=Fri Apr 17 14:09:00 CST 2020, time=2020-04-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1306434, encodeId=233b130643437, content=<a href='/topic/show?id=aeb639230b7' target=_blank style='color:#2F92EE;'>#听力#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=39230, encryptionId=aeb639230b7, topicName=听力)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=96d4340, createdName=ysjykql, createdTime=Mon Oct 14 09:09:00 CST 2019, time=2019-10-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1340189, encodeId=15c4134018977, content=<a href='/topic/show?id=d0c3e4615f2' target=_blank style='color:#2F92EE;'>#神经鞘瘤#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=74615, encryptionId=d0c3e4615f2, topicName=神经鞘瘤)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=48732500158, createdName=12498c32m68暂无昵称, createdTime=Mon Oct 14 09:09:00 CST 2019, time=2019-10-14, status=1, ipAttribution=)]
    2019-10-14 ysjykql
  5. [GetPortalCommentsPageByObjectIdResponse(id=1728162, encodeId=085f1e2816211, content=<a href='/topic/show?id=986913980dd' target=_blank style='color:#2F92EE;'>#PE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13980, encryptionId=986913980dd, topicName=PE)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f06c33759375, createdName=feather89, createdTime=Wed Nov 20 17:09:00 CST 2019, time=2019-11-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2076453, encodeId=712b20e645362, content=<a href='/topic/show?id=d7453259e86' target=_blank style='color:#2F92EE;'>#前庭神经#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=32597, encryptionId=d7453259e86, topicName=前庭神经)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ec37461, createdName=szhvet, createdTime=Wed Feb 12 14:09:00 CST 2020, time=2020-02-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1667571, encodeId=2bd2166e57146, content=<a href='/topic/show?id=b9559296103' target=_blank style='color:#2F92EE;'>#趋势分析#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=92961, encryptionId=b9559296103, topicName=趋势分析)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=20bf26147921, createdName=bugit, createdTime=Fri Apr 17 14:09:00 CST 2020, time=2020-04-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1306434, encodeId=233b130643437, content=<a href='/topic/show?id=aeb639230b7' target=_blank style='color:#2F92EE;'>#听力#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=39230, encryptionId=aeb639230b7, topicName=听力)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=96d4340, createdName=ysjykql, createdTime=Mon Oct 14 09:09:00 CST 2019, time=2019-10-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1340189, encodeId=15c4134018977, content=<a href='/topic/show?id=d0c3e4615f2' target=_blank style='color:#2F92EE;'>#神经鞘瘤#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=74615, encryptionId=d0c3e4615f2, topicName=神经鞘瘤)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=48732500158, createdName=12498c32m68暂无昵称, createdTime=Mon Oct 14 09:09:00 CST 2019, time=2019-10-14, status=1, ipAttribution=)]

相关资讯

Eur Arch Otorhinolaryngol:前庭神经鞘瘤诊断和治疗策略国际比较

最近,有研究人员比较了国际上对前庭神经鞘瘤(VS)的诊断和治疗策略情况。研究是一个基于网络的调查问卷,并发送给130名耳鼻喉科专家,并主要通过欧洲颅底协会进行鉴定。研究总共有36名来自于11个不同国家的耳鼻喉专家完成了调查问卷(恢复率28%)。VS的诊断和治疗指南的在回应者中的使用率分别为44%和42%。在VS的诊断策略中,使用听觉前庭功能测试的不同类型和组合来决定是否一个患者应该进行MRI。回应

Eur Arch Otorhinolaryngol:耳蜗微音器电位对耳蜗功能进行的非侵入型监测研究

在前庭神经鞘瘤(VS)手术中,听力保留的比例低。除了对耳蜗神经的损伤之外,手术过程中的耳蜗缺血是听力损失的一个潜在原因。最近,有研究人员利用非侵入性的耳蜗微音器电位(CM)记录探究了VS手术过程中的耳蜗血管事件。研究人员在2个经历乙状窦后桥小脑角手术病人样本中进行了连续的术中CM监测,具体是通过对80-95dB SPL和1kHz音调爆发响应的监测,其中1个样本是VS组(n=31),另一个样本是前庭

NEJM:2型神经纤维瘤病中的双侧前庭神经鞘瘤-病例报道

双侧前庭神经鞘瘤是2型神经纤维瘤病的标志。在受影响的患者中,可能在其他颅神经和周围神经、脑膜瘤、室管膜瘤和星形细胞瘤上发展为神经鞘瘤。患者可能有患有2型神经纤维瘤病的父母,这是由NF2突变引起的。这些异常以常染色体显性方式遗传,尽管也可能发生新的突变。

2019 EANO指南:前庭神经鞘瘤的诊断和治疗

2019年8月,欧洲神经肿瘤协会(EANO)发布了前庭神经鞘瘤的诊断和治疗指南,与其他颅内肿瘤相比,前庭神经鞘瘤的质量建议证据水平较低,本文主要针对前庭神经鞘瘤的诊断和治疗提出循证指导建议。

Otol Neurotol:在具有可用听力保守治疗的前庭神经鞘瘤患者中的听力结果分析

最近,有研究人员在选择初步观察的散发性前庭神经鞘瘤(VS)患者中,鉴定分析了发展为无可用听力的风险。研究是一个回顾性的案例系列研究,包括了2个高级护理中心。研究包括了那些在干预前或者跟踪调查终止前具有可用听力且经历了至少2次听力图测定和2次MRI的VS患者。研究共包括了466名患者(平均年龄为57岁,肿瘤平均直径为7.3mm),他们具有可用听力并且跟踪调查的平均时间为2.3年(IQR 1.0 -

Acta Otorrinolaringol Esp:前庭神经鞘瘤手术后双侧感音神经性听力损失研究

前庭神经鞘瘤手术后(VS)的双侧感音神经性听力损失(CSNHL)是一种严重的并发症,尤其是在那些手术侧的听力保留基本不可能。也有一些理论来解释上述问题,但是针对治疗还没有建立起指南。研究包括额4名患者,他们在研究人员所在单位进行了手术,并且后来发展为重度CSNHL。研究发现,在185个VS治疗案例中,4名(2.2%)患者在VS术后发展为CSNHL。在药物治疗之后,听力在1名患者中出现了部分的恢复,